By engineering A20 CAR5 T cells to co-express A20 CAR4 and secrete anti-PD-L1 scFv, we achieved improved tumor cytotoxicity and functionality compared to conventional A20 CAR4 T cell. Here, CD274 is linked to neoplasm.